Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Standards & Regulation

Addressing the Aduhelm Controversy

| Stephanie Vine

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

Manufacture Technology and Equipment

The Next Level: Pharma Meets Video Game Tech

| Stephanie Vine

Get ready for medicine making level 2 as video games come to healthcare backed with clinical trial data that demonstrate efficacy.

Manufacture Analytical Science

Understanding Bad Behavior

| Stephanie Vine

Researchers explain how they used video games to explore human behavior when it comes to producing pharma products.

Discovery & Development Digital Technologies

A Pain-Free Reality

| Stephanie Vine

Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Manufacture Ingredients

Moving Away From “Quality by Fear”: Part II

| Stephanie Vine

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Manufacture Ingredients

Moving Away From “Quality by Fear”: Part I

| Stephanie Vine

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Discovery & Development Technology and Equipment

The story behind an FDA-Approved Video Game Treatment for ADHD

| Stephanie Vine

We find out more about the video game that won FDA approval as a treatment for children with ADHD

Manufacture Contract Manufacturing Services

The Greener, Cleaner Path

| Stephanie Vine

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Vine

After other defendants in the case settle, Teva is left to face the music in New York alone.

Manufacture Advanced Medicine

Can Cell Therapies Take on Solid Tumors?

| Stephanie Vine

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register